Appropriate use of oral corticosteroids for severe asthma

被引：42
|
作者：
Ramsahai, J. Michael [1 ]
Wark, Peter A. B. [1 ]
机构：
[1] Univ Newcastle, Hunter Med Res Inst, Ctr Hlth Lungs, Newcastle, NSW, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2018年 / 209卷
关键词：
OMALIZUMAB; MANAGEMENT; HYPERRESPONSIVENESS; COMPLICATIONS; PREDNISOLONE; EOSINOPHILS; MECHANISMS; PHENOTYPES;
D O I：
10.5694/mja18.00134
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S18 / S21
页数：4
相关论文
共 50 条
  • [1] Evaluation of Asthma control and oral corticosteroids in Severe Asthma
    Micheletto, Claudio
    Bilo, Maria Beatrice
    Antonicelli, Leonardo
    De Michele, Fausto
    Musarra, Antonino
    Vagni, Adriano
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [2] Oral corticosteroids in the treatment of exacerbation of severe asthma
    Gevorgyan, Anahit
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [3] Reducing oral corticosteroids in severe asthma (ROSA Project): a nationwide Portuguese consensus
    Loureiro, Claudia Chaves
    Ferreira, Manuel Branco
    Ferreira, Jorge
    Lima, Ricardo
    Marques, Joao
    Sokolova, Anna
    Tonin, Fernanda S.
    Ramos, Filipa Duarte
    PULMONOLOGY, 2021, 27 (04): : 313 - 327
  • [4] Rational oral corticosteroid use in adult severe asthma: A narrative review
    Chung, Li Ping
    Upham, John W.
    Bardin, Philip G.
    Hew, Mark
    RESPIROLOGY, 2020, 25 (02) : 161 - 172
  • [5] Use of Oral Corticosteroids in the Wheezy Toddler
    Abrams, Elissa M.
    Becker, Allan B.
    Szefler, Stanley J.
    JOURNAL OF PEDIATRICS, 2018, 201 : 16 - 20
  • [6] Expert consensus on oral corticosteroids stewardship for the treatment of severe asthma in the Middle East and Africa
    Al-Ahmad, Mona
    Al Zaabi, Ashraf
    Madkour, Ashraf
    Alqaraghuli, Haider Abdulhameed
    Al Hayaan, Hajar
    Mobayed, Hassan
    Idrees, Majdy
    Al Busaidi, Nasser
    Zeineldine, Salah
    RESPIRATORY MEDICINE, 2024, 228
  • [7] Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?
    Menzella, Francesco
    Latorre, Manuela
    Ruggiero, Patrizia
    Bagnasco, Diego
    Heffler, Enrico
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (07) : 601 - 606
  • [8] Severe Asthma Patients: Can We Really Wean Them off of Oral Corticosteroids
    Pozo-Beltran, Cesar Fireth
    Elizondo-Villarreal, Barbara
    Morett-Vera, Fernando
    Gonzalez-Uribe, Victor
    Rodriguez-Romo, Roxana Minerva
    Navarrete-Rodriguez, Elsy Maureen
    Paniagua-Santos, Jorge Andres
    Ledezma-Ortega, Jesus Fernando
    Briceno-Gamboa, Adriana Virginia
    CURRENT TREATMENT OPTIONS IN ALLERGY, 2023, 10 (03) : 215 - 231
  • [9] Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patients
    Latorre, Manuela
    Rizzi, Angela
    Paggiaro, Pierluigi
    Baiardini, Ilaria
    Bagnasco, Diego
    Del Giacco, Stefano
    Lombardi, Carlo
    Patella, Vincenzo
    Nucera, Eleonora
    Parente, Roberta
    Paoletti, Giovanni
    Pini, Laura
    Ridolo, Erminia
    Senna, Gianenrico
    Blasi, Francesco
    Canonica, Giorgio Walter
    JOURNAL OF ASTHMA, 2024, 61 (10) : 1294 - 1305
  • [10] Medication Adherence in Patients With Severe Asthma Prescribed Oral Corticosteroids in the U-BIOPRED Cohort
    Alahmadi, Fahad H.
    Simpson, Andrew J.
    Gomez, Cristina
    Ericsson, Magnus
    Thorngren, John-Olof
    Wheelock, Craig E.
    Shaw, Dominic E.
    Fleming, Louise J.
    Roberts, Graham
    Riley, John
    Bates, Stewart
    Sousa, Ana R.
    Knowles, Richard
    Bansal, Aruna T.
    Corfield, Julie
    Pandis, Ioannis
    Sun, Kai
    Bakke, Per S.
    Caruso, Massimo
    Chanez, Pascal
    Dahlen, Barbro
    Horvath, Ildiko
    Krug, Norbert
    Montuschi, Paolo
    Singer, Florian
    Wagers, Scott
    Adcock, Ian M.
    Djukanovic, Ratko
    Chung, Kian Fan
    Sterk, Peter J.
    Dahlen, Sven-Erik
    Fowler, Stephen J.
    CHEST, 2021, 160 (01) : 53 - 64
12345